A new regulatory milestone: what the joint FDA and EMA’s AI principles can mean for clinical trial technology
Author: Elizabeth Lavin, Chief Quality Officer, Suvoda
IRT vs. RTSM: what’s the difference? What sponsors need to know when choosing clinical trial technology
Author: Heather Nonnemacher, Director of Services Solutions, Suvoda
Technology fragmentation is one of the biggest hidden risks in clinical trials
By Kathy Kohler, Vice President, Customer Success at Suvoda
Greenphire Clinical Finance—Budgeting & Benchmarking: FAQs for clinical trial sponsors, CROs, and sites
What is our Budgeting & Benchmarking software solution and who is it for? Budgeting & Benchmarking...
What is the Suvoda patient app for clinical trials?
A mobile patient app that puts clinical trial needs like questionnaires, payments, and travel right...
What patients are asking for in clinical trials, according to the CISCRP 2025 survey
Editor: Dave Hine, Senior Director, Solutions Consulting at Suvoda
RTSM (IRT) FAQ: A guide to Randomization and Trial Supply Management technology for clinical trials
What you need to know about RTSM software systems, also known as Interactive Response Technology...
Clinical trial technology 2026 outlook: five big ideas from Suvoda leaders
Author: Elena Filimonova, Chief Marketing Officer
A conversation with E.K. Koh, Chief Product Officer: how Suvoda is shaping the future of clinical trial technology
Author: Elena Filimonova, Chief Marketing Officer
Less friction, more focus: Rethinking technology for patients and sites in clinical trials
Author: Heather Nonnemacher, Director of Services Solutions, Suvoda